. 2020 Apr 29;9(2):e17863. doi: 10.2196/17863

Table 2.

Change in assessment values at 8 weeks, compared with baseline, for the overall group and by nebulized admixture.

Assessment	Nebulized ICS^a + bronchodilators^b (n=53)		Nebulized formoterol/budesonide + glycopyrronium (n=40)		Nebulized formoterol/budesonide (n=13)
	Change	P value^c	Change	P value^c		Change	P value^c
Pre-bronchodilator FEV1^d (L), mean (SD)	0.46 (0.58)	<.001	0.54 (0.51)	<.001		0.22 (0.25)	<.001
GINA^e asthma control score (points), mean (SD)	–1.8 (0.8)	<.001	–1.8 (1.0)	<.001		–1.8 (1.0)	<.001

^aICS: inhaled corticosteroid.

^bbeta 2 agonists or anticholinergics.

^cCompared with baseline.

^dFEV1: forced expiratory volume in one second.

^eGINA: Global Initiative for Asthma.